Moreover, HIF-1α plays a crucial role in the pathogenesis of PEL, an aggressive B-cell lymphoma with a poor prognosis caused by KSHV, which promotes the activity of HIF-1α and, in turn, activates the KSHV gene. The gene discussed is HIF1A; the disease is B-cell non-Hodgkin lymphoma.